COL11A1 and cancer: Given that we and others have observed an increase in COL11A1 expression in ovarian and other cancer types, post-chemotherapy, this study is particularly informative because it provides an in-depth understanding of the factors that drive COL11A1 expression in drug-resistant cancer cells that might ultimately cause recurrence.